- Home
- BNZI vs SNSE Comparison
BNZI vs SNSE Comparison
Compare BNZI & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNZI
- SNSE
- Stock Information
- Founded
- BNZI 2016
- SNSE 2005
- Country
- BNZI United States
- SNSE United States
- Employees
- BNZI N/A
- SNSE N/A
- Industry
- BNZI
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- BNZI
- SNSE Health Care
- Exchange
- BNZI Nasdaq
- SNSE Nasdaq
- Market Cap
- BNZI 12.3M
- SNSE 10.8M
- IPO Year
- BNZI N/A
- SNSE 2021
- Fundamental
- Price
- BNZI $3.26
- SNSE $8.80
- Analyst Decision
- BNZI Strong Buy
- SNSE Strong Buy
- Analyst Count
- BNZI 1
- SNSE 4
- Target Price
- BNZI $240.00
- SNSE $72.50
- AVG Volume (30 Days)
- BNZI 404.3K
- SNSE 33.8K
- Earning Date
- BNZI 08-14-2025
- SNSE 08-05-2025
- Dividend Yield
- BNZI N/A
- SNSE N/A
- EPS Growth
- BNZI N/A
- SNSE N/A
- EPS
- BNZI N/A
- SNSE N/A
- Revenue
- BNZI $9,021,543.00
- SNSE N/A
- Revenue This Year
- BNZI $337.60
- SNSE N/A
- Revenue Next Year
- BNZI $91.81
- SNSE N/A
- P/E Ratio
- BNZI N/A
- SNSE N/A
- Revenue Growth
- BNZI 107.94
- SNSE N/A
- 52 Week Low
- BNZI $2.65
- SNSE $5.00
- 52 Week High
- BNZI $112.00
- SNSE $17.40
- Technical
- Relative Strength Index (RSI)
- BNZI 44.71
- SNSE 58.20
- Support Level
- BNZI $3.60
- SNSE $7.31
- Resistance Level
- BNZI $4.23
- SNSE $9.22
- Average True Range (ATR)
- BNZI 0.49
- SNSE 0.99
- MACD
- BNZI 0.17
- SNSE 0.09
- Stochastic Oscillator
- BNZI 55.17
- SNSE 46.84
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).